Loading provider…
Loading provider…
Nephrology Physician in Houston, TX
NPI: 1114008513Primary Employer
Physicians Referral Service
mdanderson.org
HQ Phone
Get MD Ala's Phone Numberphone_androidMobile
Get MD Ala's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
FL State Medical License
2021
TN State Medical License
2023 - 2027
WA State Medical License
2023 - 2026
AL State Medical License
2024 - 2025
AZ State Medical License
2023 - 2025
GA State Medical License
2023 - 2025
LA State Medical License
2023 - 2025
MS State Medical License
2023 - 2025
OK State Medical License
2020 - 2025
TX State Medical License
2006 - 2025

American Board of Internal Medicine
Nephrology
McGovern Medical School
med.uth.edu
Medical School
Until 2003
Baylor College Of Medicine
bcm.edu
Fellowship • Nephrology
2009 - 2011
Residency • Internal Medicine
2003 - 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 124 | 317 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 79 | 140 |
| 3 | 99221Initial hospital inpatient care, typically 30 minutes per day | 53 | 55 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 42 | 56 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 39 | 39 |
Are Antiemetics the Next Therapeutic Strategy against Cisplatin-Associated Acute Kidney Injury?
Authors: Shveta Motwani
Journal: Kidney360
Magnesium: An Overlooked Electrolyte.
Authors: Jaya Kala
Journal: Adv Kidney Dis Health
Lead Sponsor: Foundation for the National Institutes of Health
Collaborators: Merck Sharp & Dohme LLC, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Southern California, AstraZeneca, Pfizer, University of Minnesota, Eli Lilly and Company, Brigham and Women's Hospital, Amgen, M.D. Anderson Cancer Center, Johnson & Johnson, Critical Path Institute - Predictive Safety Testing Consortium